Scientific collaboration between Elucidata and Auron
Company & Culture

Scientific collaboration between Elucidata and Auron

Vipul Jain
January 15, 2019

Auron Therapeutics and Elucidata Corporation recently announced a four year collaboration using Elucidata’s Polly. It is an AI-based target discovery platform to identify and validate targets for differentiation-based therapy for Acute Myeloid Leukemia (AML) and other oncology indications.

Elucidata will use Polly, to analyze transcriptomic, metabolomic and epigenetic data from biological samples along with treatment data from patients.

Read more on BusinessWire

Subscribe to our newsletter
Only data insights. No spam!
Thank you! Please click on the link to start the download.
Download Now
Oops! Something went wrong while submitting the form.

Blog Categories